Gujilde, Celso M.

HRN: 21-41-61  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/01/2022
06/08/2022
IV
4.5g
Q6hours
CAP-HR
Waiting Final Action 
06/04/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/04/2022
06/08/2022
TOPICAL
25gm
BID
Infected Wound Right Heel
Waiting Final Action 
06/13/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/13/2022
06/15/2022
TOPICA
Ample Amount
Bid
Decubitus Ulcer (sacral Area)
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: